Assessment of corticosteroid-induced alkaline phosphatase as a prognostic indicator in canine lymphoma

A. L. Wiedemann, S. C. Charney, A. M. Barger, D. J. Schaeffer, B. E. Kitchell

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVES: To examine the incidence of elevated corticosteroid-induced alkaline phosphatase (sALP) in dogs with lymphoma and to determine if sALP is a reliable prognostic indicator in canine lymphoma. METHODS: The medical records of 62 canine lymphoma patients treated with a combination chemotherapy protocol from 1994 to 2003 at the University of Illinois Veterinary Teaching Hospital were examined. Variables assessed with respect to response rate and remission duration included age, bodyweight, sex, breed, World Health Organization stage (I to V), substage (a or b), pretreatment administration of corticosteroid, and serum levels of alkaline phosphatase, sALP and alanine aminotransferase. RESULTS: sALP was not statistically significant with respect to response rate or duration of remission, nor was preinduction glucocorticoid administration. Stage was significant with respect to achieving remission. CLINICAL SIGNIFICANCE: It was found that sALP is not a useful prognostic indicator for response rate and remission duration in dogs with lymphoma.

Original languageEnglish (US)
Pages (from-to)185-190
Number of pages6
JournalJournal of Small Animal Practice
Volume46
Issue number4
DOIs
StatePublished - Apr 2005

ASJC Scopus subject areas

  • Small Animals

Fingerprint

Dive into the research topics of 'Assessment of corticosteroid-induced alkaline phosphatase as a prognostic indicator in canine lymphoma'. Together they form a unique fingerprint.

Cite this